Daiichi Sankyo to Buy Plexxikon for Up to $935 Million

Daiichi Sankyo Co., Japan’s third-largest drugmaker, agreed to buy Plexxikon Inc. for as much as $935 million, accelerating its expansion into cancer medicines.
Bloomberg